Claude Caron Fromentel

Claude Caron de Fromentel

UNVERIFIED PROFILE

Are you Claude Caron de Fromentel?   Register this Author

Register author
Claude Caron Fromentel

Claude Caron de Fromentel

Publications by authors named "Claude Caron de Fromentel"

20Publications

286Reads

46Profile Views

1PubMed Central Citations

Disequilibrium of BMP2 levels in the breast stem cell niche launches epithelial transformation by overamplifying BMPR1B cell response.

Stem Cell Reports 2015 Feb 15;4(2):239-54. Epub 2015 Jan 15.

CNRS UMR5286, Centre de Recherche en Cancérologie de Lyon, 69000 Lyon, France; Inserm U1052, Centre de Recherche en Cancérologie de Lyon, 69000 Lyon, France; Université de Lyon, 69000 Lyon, France; Department of Immunity, Virus, and Microenvironment, 69000 Lyon, France; Université de Lyon 1, ISPB, 69000 Lyon, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.stemcr.2014.12.007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4325271PMC
February 2015

Wnt signaling and hepatocarcinogenesis: molecular targets for the development of innovative anticancer drugs.

J Hepatol 2013 Nov 5;59(5):1107-17. Epub 2013 Jul 5.

INSERM U1052, CNRS UMR5286, Centre de Recherche en Cancérologie de Lyon, F-69008 Lyon, France; Université Lyon-1, F-69622 Villeurbanne, France; Centre Léon Bérard, F-69008 Lyon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2013.07.001DOI Listing
November 2013

[The two faces of p63, Janus of the p53 gene family].

Med Sci (Paris) 2012 Apr 25;28(4):381-7. Epub 2012 Apr 25.

Inserm U1052, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1051/medsci/2012284015DOI Listing
April 2012

[When p53 mutants engage in trafficking!].

Med Sci (Paris) 2010 Oct;26(10):814-6

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1051/medsci/20102610814DOI Listing
October 2010

Cancer stem cells: the emerging challenge of drug targeting.

Curr Med Chem 2009 ;16(4):394-416

Université de Lyon, Inserm, U590 Centre Léon Bérard, 28 Rue Laennec, 69373 Lyon Cedex 08, France.

View Article

Download full-text PDF

Source
April 2009

In vitro and in vivo cytotoxic effects of PRIMA-1 on hepatocellular carcinoma cells expressing mutant p53ser249.

Carcinogenesis 2008 Jul 28;29(7):1428-34. Epub 2007 Nov 28.

International Agency for Research on Cancer, 150 cours Albert Thomas, 69372 Lyon Cedex 08, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/carcin/bgm266DOI Listing
July 2008

Gadd45a activation protects melanoma cells from ultraviolet B-induced apoptosis.

J Invest Dermatol 2008 Jan 16;128(1):196-202. Epub 2007 Aug 16.

INSERM U590 Oncogenèse et Progression Tumorale, Lyon cedex 08, Lyon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/sj.jid.5700963DOI Listing
January 2008

TP63 gene in stress response and carcinogenesis: a broader role than expected.

Bull Cancer 2006 Dec;93(12):E126-35

International Agency for Research on Cancer, 150 cours Albert-Thomas, 69372 Lyon Cedex 08, France.

View Article

Download full-text PDF

Source
December 2006

UVB-induced G2 arrest of human melanocytes involves Cdc2 sequestration by Gadd45a in nuclear speckles.

Cell Cycle 2006 Aug 15;5(16):1859-64. Epub 2006 Aug 15.

INSERM U590, Oncogenèse et Progression Tumorale, Université Lyon1, Centre Léon Bérard, Lyon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/cc.5.16.3119DOI Listing
August 2006

p53 as a target for anti-cancer drug development.

Crit Rev Oncol Hematol 2006 Jun 9;58(3):190-207. Epub 2006 May 9.

INSERM U590, Centre Léon Bérard, 28 rue Laënnec, 69373 Lyon Cedex 08, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.critrevonc.2005.10.005DOI Listing
June 2006

WITHDRAWN: Expression of p53, p63, and p73 isoforms in squamous cell carcinoma and adenocarcinoma of esophagus☆,☆☆

Biochem Biophys Res Commun 2005 Aug 22;336(1):339-345. Epub 2005 Aug 22.

Unit of Molecular Carcinogenesis, International Agency for Research on Cancer (IARC), 150 Cours Albert Thomas, 69372 Lyon Cedex 08, France.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S0006291X0501773
Publisher Site
http://dx.doi.org/10.1016/j.bbrc.2005.08.084DOI Listing
August 2005

The tumor suppressor gene TP53: implications for cancer management and therapy.

Crit Rev Clin Lab Sci 2004 ;41(5-6):551-83

International Agency for Research on Cancer, Lyon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10408360490504952 DOI Listing
March 2005

The expression of TA and DeltaNp63 are regulated by different mechanisms in liver cells.

Oncogene 2005 Jan;24(3):512-9

International Agency for Research on Cancer, 150 cours A Thomas, 69372 Lyon Cedex 08, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/sj.onc.1208215DOI Listing
January 2005

A new set of monoclonal antibodies directed to proline-rich and central regions of p53.

Hybrid Hybridomics 2004 Oct;23(5):287-92

INSERM U590, Centre Léon Bérard, Lyon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/hyb.2004.23.287DOI Listing
October 2004

TP53 mutation spectra and load: a tool for generating hypotheses on the etiology of cancer.

IARC Sci Publ 2004 (157):247-70

Laboratory of Human Carcinogenesis, Division of Cancer Etiology, National Cancer Institute, NIH, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
April 2004

p53 protein variants: structural and functional similarities with p63 and p73 isoforms.

Oncogene 2004 Jan;23(3):631-8

Unit of Molecular Carcinogenesis, International Agency for Research on Cancer, 150 cours Albert Thomas, 69372 Lyon Cedex 08, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/sj.onc.1206929DOI Listing
January 2004